| Date | Title | Description |
| 29.10.2024 | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Australia | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Australia
Tue, Oct 29, 2024 11:27 CET Report this content
SyntheticMR, global leader in advanced quantitative imaging solutions, is thrilled to announce that its SyMRI 15 solution has... |
| 02.10.2024 | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland
Wed, Oct 02, 2024 10:15 CET Report this content
SyntheticMR AB, global leader in advanced quantitative imaging software, is pleased to announce that its SyMRI 15 solution ... |
| 25.09.2024 | SyntheticMR Announces Regulatory Clearance for SyMRI 15 in the UK | SyntheticMR Announces Regulatory Clearance for SyMRI 15 in the UK
Wed, Sep 25, 2024 10:00 CET Report this content
SyntheticMR, leader in quantitative imaging software, is pleased to announce that its SyMRI 15 solution has received regulator... |
| 04.09.2024 | SyntheticMR Announces the Appointment of Francois Hebert as New President, North America | SyntheticMR Announces the Appointment of Francois Hebert as New President, North America
Wed, Sep 04, 2024 10:00 CET Report this content
SyntheticMR is thrilled to announce the appointment of Francois Hebert as the new President of Syntheti... |
| 27.08.2024 | Interim report April – June 2024 | Interim report April – June 2024
Tue, Aug 27, 2024 08:49 CET Report this content
Second quarter in brief
Net sales amounted to 11.9 million SEK (21.2), which means a decrease in sales of 44 percent.
Operating profit amounted to -8.2 million... |
| 19.08.2024 | SyntheticMR Receives Regulatory Approval for SyMRI in Taiwan | SyntheticMR Receives Regulatory Approval for SyMRI in Taiwan
Mon, Aug 19, 2024 10:48 CET Report this content
SyntheticMR announced today that its quantitative imaging software solution, SyMRI 12, has received regulatory approval from the Ta... |
| 09.07.2024 | SyntheticMR announces estimated net sales of SEK 12m. (21.2) for quarter 2 of 2024 depending on organizational changes in USA. The net sales target for 2024 is therefore not expected to be achieved | SyntheticMR announces estimated net sales of SEK 12m. (21.2) for quarter 2 of 2024 depending on organizational changes in USA. The net sales target for 2024 is therefore not expected to be achieved
Tue, Jul 09, 2024 21:34 CET Report this co... |
| 26.06.2024 | SyMRI 15 by SyntheticMR obtains CE-Marking | SyMRI 15 by SyntheticMR obtains CE-Marking
Wed, Jun 26, 2024 13:30 CET Report this content
SyntheticMR announced today that version 15 of their next-generation imaging solution, SyMRI Neuro, has obtained CE-marking.
SyMRI 15 is a cutting-ed... |
| 22.05.2024 | Report from Annual General Meeting in SyntheticMR AB (publ) | Report from Annual General Meeting in SyntheticMR AB (publ)
Wed, May 22, 2024 08:22 CET Report this content
The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 21, 2024, whereby the meeting resolved in accordance with ... |
| 21.05.2024 | Interim report January – March 2024 | Interim report January – March 2024
Tue, May 21, 2024 08:08 CET Report this content
First quarter in brief
Net sales amounted to 17.8 million SEK (16.1), which means a sales growth of 10 percent.
Operating profit amounted to 2.7 million SEK... |
| 19.04.2024 | SyntheticMR publishes annual report for 2023 | SyntheticMR publishes annual report for 2023
Fri, Apr 19, 2024 07:31 CET Report this content
SyntheticMR AB (publ) hereby announces that the Group´s annual report for 2023 has been published.
The annual report is also available on Synthetic... |
| 19.04.2024 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | Notice to attend the annual general meeting of SyntheticMR AB (publ)
Fri, Apr 19, 2024 08:01 CET Report this content
The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general ... |
| 17.04.2024 | SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities. | SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities.
Wed, Apr 17, 2024 10:15 CET Report this content
SimonM... |
| 27.03.2024 | SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D | SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D
Wed, Mar 27, 2024 11:01 CET Report this content
SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3... |
| 16.03.2024 | Rimes Launches AI-powered Data Lakehouse Copilot for Natural Language Insights | Rimes is pleased to announce the launch of its Data Lakehouse Copilot. The Large Language Model (LLM) powered by the AI Copilot quickly provides unique insights from data using natural language. The initial focus for the AI Copilot is to su... |
| 13.03.2024 | First Advantage Introduces RightID to Detect Job Applicant Fraud in Pre-Hire Process | Multi-Layered Approach Designed to Flag Inconsistencies and Deep-Fake Efforts Delivers a Consistent, Secure Solution to Growing Problem
First Advantage Corporation, a leading provider of employment background screening, identity, and verifi... |
| 13.03.2024 | HKUST Introduces Asia’s First “AI Lecturers” in Class to Promote Teaching Innovation | A New Initiative to Foster Cross-Campus Study in HK and Guangzhou
Following the birth of “AI singers” and “AI weather presenters”, adding to the ever-expanding AI (Artificial Intelligence) family is the inaugural cohort of “AI Lecturers” cr... |
| 12.03.2024 | Philips and SyntheticMR Collaboration Advances AI in MRI Diagnostic Imaging: GlobalData | Philips recently announced a collaboration with SyntheticMR to develop quantitative brain imaging tools powered by artificial intelligence (AI) to diagnose disorders such as multiple sclerosis (MS), traumatic brain injury, and dementia. Wit... |
| 12.03.2024 | Decided allocation regarding incentive program LTIP 2024 and TO 2 | Decided allocation regarding incentive program LTIP 2024 and TO 2
Tue, Mar 12, 2024 18:12 CET Report this content
At the extraordinary general meeting on February 20, 2024, it was decided to introduce the incentive program LTIP 2024 for per... |
| 05.03.2024 | Fixed subscription price for warrants of series TO 2 and TO 3 | Fixed subscription price for warrants of series TO 2 and TO 3
Tue, Mar 05, 2024 21:54 CET Report this content
At the extraordinary general meeting on February 20, 2024, it was decided to introduce the incentive program LTIP 2024 for personn... |
| 01.03.2024 | Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients | Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients
Fri, Mar 01, 2024 09:00 CET Report this content
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in... |
| 20.02.2024 | Year-End report January – December 2023 | Year-End report January – December 2023
Tue, Feb 20, 2024 08:09 CET Report this content
Fourth quarter in brief
Net sales amounted to 30.1 million SEK (20.6), which means a sales growth of 46 percent.
Operating profit amounted to 8.8 millio... |
| 20.02.2024 | Report from the extraordinary general meeting in SyntheticMR AB (publ) | Report from the extraordinary general meeting in SyntheticMR AB (publ)
Tue, Feb 20, 2024 16:18 CET Report this content
Today, the 20th of February 2024, an extraordinary general meeting was held in SyntheticMR AB (publ). Below is a summary ... |
| 19.01.2024 | Notice to attend the extraordinary general meeting of SyntheticMR AB (publ) | Notice to attend the extraordinary general meeting of SyntheticMR AB (publ)
Fri, Jan 19, 2024 13:50 CET Report this content
Shareholders in SyntheticMR AB (publ), corporate Reg. NO. 556723-8877, are hereby invited to attend an extraordinary... |
| 18.12.2023 | SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking | SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking
Mon, Dec 18, 2023 10:00 CET Report this content
SyntheticMR announced today that their next-generation imaging solution with isotropic 3D resolution, SyM... |
| 13.12.2023 | SYNTHETICMR RECEIVES SIGNIFICANT ORDER FROM OEM PARTNER | SYNTHETICMR RECEIVES SIGNIFICANT ORDER FROM OEM PARTNER
Wed, Dec 13, 2023 08:54 CET Report this content
SyntheticMR announced today that they have received an order from an OEM partner.
The order is for licenses of SyntheticMR’s product pac... |
| 30.11.2023 | SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D | LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D.
The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be incl... |
| 30.11.2023 | SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D | SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D
Thu, Nov 30, 2023 09:43 CET Report this content
SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D.
The expanded a... |
| 22.11.2023 | SyntheticMR Has Submitted Their Next Generation Solution, SyMRI 3D for 510(k) Clearance | SyntheticMR Has Submitted Their Next Generation Solution, SyMRI 3D for 510(k) Clearance
Wed, Nov 22, 2023 08:48 CET Report this content
SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI... |
| 10.11.2023 | Interim report July – September 2023 | Interim report July – September 2023
Fri, Nov 10, 2023 08:11 CET Report this content
Third quarter in brief
Net sales amounted to 21.7 million SEK (19.0), which means a sales growth of 14 percent.
Operating profit amounted to 4.5 million SE... |
| 22.08.2023 | Interim report April – June 2023 | Interim report April – June 2023
Tue, Aug 22, 2023 08:05 CET Report this content
Second quarter in brief
Net sales amounted to 21.2 million SEK (18.7), which means a sales growth of 13 percent.
Operating profit amounted to 2.8 million SEK (... |
| 13.06.2023 | SyntheticMR Introduces Quantitative Neuro Reports to Enhance Clinical Workflow | SyntheticMR Introduces Quantitative Neuro Reports to Enhance Clinical Workflow
Tue, Jun 13, 2023 10:00 CET Report this content
SyntheticMR has released a new update to SyMRI 11.3.11 & 12.1.11 that provides condensed and relevant quantit... |
| 31.05.2023 | SyntheticMR Receives Regulatory Approval for their Innovative SyMRI Software Solution in South Korea | SyntheticMR Receives Regulatory Approval for their Innovative SyMRI Software Solution in South Korea
Wed, May 31, 2023 10:00 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI 12.1 ha... |
| 24.05.2023 | Report from Annual General Meeting in SyntheticMR AB (publ) | Report from Annual General Meeting in SyntheticMR AB (publ)
Wed, May 24, 2023 08:32 CET Report this content
The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 23, 2023, whereby the meeting resolved in accordance with ... |
| 23.05.2023 | Interim report January – March 2023 | Interim report January – March 2023
Tue, May 23, 2023 08:08 CET Report this content
First quarter in brief
Net sales amounted to 16,1 million SEK (9,9), which means a sales growth of 63 percent.
Operating profit amounted to -2 million SEK (... |
| 14.04.2023 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | Notice to attend the annual general meeting of SyntheticMR AB (publ)
Fri, Apr 14, 2023 07:22 CET Report this content
The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general ... |
| 11.04.2023 | SyntheticMR publishes annual report for 2022 | SyntheticMR publishes annual report for 2022
Tue, Apr 11, 2023 08:40 CET Report this content
SyntheticMR AB (publ) hereby announces that the Group´s annual report for 2022 has been published.
The annual report is also available on Synthetic... |
| 24.03.2023 | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Singapore | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Singapore
Fri, Mar 24, 2023 11:21 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI 12.1 has received regulato... |
| 02.03.2023 | SyntheticMR’s Receives Regulatory Clearance for SyMRI in the UK | SyntheticMR’s Receives Regulatory Clearance for SyMRI in the UK
Thu, Mar 02, 2023 10:02 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory clearance in the UK.... |
| 27.02.2023 | SyntheticMR’s Innovative Software Receives Regulatory Approval in Canada | SyntheticMR’s Innovative Software Receives Regulatory Approval in Canada
Mon, Feb 27, 2023 10:12 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory approval in... |
| 15.02.2023 | Update regarding call options issued by the main owners to senior executives | Update regarding call options issued by the main owners to senior executives
Wed, Feb 15, 2023 18:02 CET Report this content
On August 27, 2021, SyntheticMR AB (publ) ("SyntheticMR") announced that the company's principal sharehol... |
| 15.02.2023 | Year-End report January – December 2022 | Year-End report January – December 2022
Wed, Feb 15, 2023 08:09 CET Report this content
Fourth quarter in brief
Net sales amounted to 20,6 million SEK (18,4), which means a sales growth of 12 percent.
Operating profit amounted to 2,1 millio... |
| 08.12.2022 | SyntheticMR signs sales agreement regarding SyMRI NEURO | SyntheticMR signs sales agreement regarding SyMRI NEURO
Thu, Dec 08, 2022 13:02 CET Report this content
SyntheticMR announces today that they have reached an agreement with one of their partners, which is a world-leading manufacturer of MRI... |
| 17.11.2022 | Nomination Committee appointed for the 2023 Annual General Meeting in SyntheticMR | Nomination Committee appointed for the 2023 Annual General Meeting in SyntheticMR
Thu, Nov 17, 2022 15:43 CET Report this content
The following shareholders have been identified as the three largest shareholders as of 2022-09-30 who are wil... |
| 16.11.2022 | Interim report July – September 2022 | Interim report July – September 2022
Wed, Nov 16, 2022 07:46 CET Report this content
Third quarter in brief
Net sales amounted to 19.0 million SEK (13.6), which means a sales growth of 40 percent.
Operating profit amounted to 4.4 million SE... |
| 28.10.2022 | SyntheticMR receives their EU Medical Device Regulation (MDR) certificate | SyntheticMR receives their EU Medical Device Regulation (MDR) certificate
Fri, Oct 28, 2022 12:01 CET Report this content
SyntheticMR announced today that they have received their EU Medical Device Regulation (MDR) certificate. This is a ne... |
| 06.09.2022 | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Malaysia | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Malaysia
Tue, Sep 06, 2022 09:00 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory app... |
| 29.08.2022 | SyntheticMR expands with a new subsidiary in Japan | SyntheticMR expands with a new subsidiary in Japan
Mon, Aug 29, 2022 11:04 CET Report this content
SyntheticMR announced today that they are expanding with a new subsidiary in Japan. The subsidiary will be led by Yusuke Shimizu, Head of Sal... |
| 23.08.2022 | Interim report April – June 2022 | Interim report April – June 2022
Tue, Aug 23, 2022 08:11 CET Report this content
Second quarter in brief
Net sales amounted to 18.7 million SEK (11.8), which means a sales growth of 59 percent.
Operating profit amounted to 4.4 million SEK (... |
| 13.07.2022 | SyntheticMR’s quantitative MRI solution SyMRI NEURO compatible with Philips SmartSpeed to support shorter scan times | SyntheticMR’s quantitative MRI solution SyMRI NEURO compatible with Philips SmartSpeed to support shorter scan times
Wed, Jul 13, 2022 11:00 CET Report this content
SyntheticMR announced today that their product SyMRI NEURO and Philips Smar... |
| 05.07.2022 | Dr. Jeff Miller of Phoenix Children’s Joins SyntheticMR’s Medical Advisory Board | Dr. Jeff Miller of Phoenix Children’s Joins SyntheticMR’s Medical Advisory Board
Tue, Jul 05, 2022 15:00 CET Report this content
SyntheticMR is thrilled to announce the appointment of Dr. Jeff Miller to their Medical Advisory Board.
Dr. Mil... |
| 30.06.2022 | SyntheticMR announces new subsidiary in India | SyntheticMR announces new subsidiary in India
Thu, Jun 30, 2022 10:10 CET Report this content
SyntheticMR announced today that they have established a subsidiary in India. This will be the company’s second subsidiary, following the establis... |
| 30.05.2022 | SyMRI MSK from SyntheticMR is now available on syngo.via Open Apps from Siemens Healthineers | SyMRI MSK from SyntheticMR is now available on syngo.via Open Apps from Siemens Healthineers
Mon, May 30, 2022 10:45 CET Report this content
The SyMRI MSK package supports a fast imaging workflow and enhanced capabilities to view tissue pro... |
| 10.05.2022 | Interim report January – March 2022 | Interim report January – March 2022
Tue, May 10, 2022 08:06 CET Report this content
First quarter in brief
Net sales amounted to 9.9 million SEK (14.7), which represents a decrease in sales of 33 percent.
Operating profit amounted to -3.6 m... |
| 08.04.2022 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | Notice to attend the annual general meeting of SyntheticMR AB (publ)
Fri, Apr 08, 2022 08:30 CET Report this content
The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general ... |
| 08.04.2022 | SyntheticMR publishes annual report for 2021 | SyntheticMR publishes annual report for 2021
Fri, Apr 08, 2022 08:26 CET Report this content
SyntheticMR AB (publ) hereby announces that the Group´s annual report for 2021 has been published.
The annual report is also available on Synthetic... |
| 05.04.2022 | SyntheticMR announces estimated net sales for the first quarter 2022 due to delays in customers' purchasing processes | SyntheticMR announces estimated net sales for the first quarter 2022 due to delays in customers' purchasing processes
Tue, Apr 05, 2022 18:26 CET Report this content
There is a great interest in and demand for SyntheticMR's products in all ... |
| 05.04.2022 | SyntheticMR to create new normative database for quantitative brain values | SyntheticMR to create new normative database for quantitative brain values
Tue, Apr 05, 2022 09:20 CET Report this content
SyntheticMR is collaborating with Mahajan Imaging in New Delhi, India, to gather reference values for the Indian popu... |
| 29.03.2022 | Announcement from SyntheticMR's extra general meeting | Announcement from SyntheticMR's extra general meeting
Tue, Mar 29, 2022 18:57 CET Report this content
The extra general meeting of SyntheticMR AB (publ) ("SyntheticMR" or the "Company") was held today on 29 March 2022 an... |
| 10.03.2022 | SyntheticMR announces its intention to carry out a directed issue of new shares | SyntheticMR announces its intention to carry out a directed issue of new shares
Thu, Mar 10, 2022 17:31 CET Report this content
SyntheticMR AB (publ) (”SyntheticMR” or the ”Company”) (listed on Spotlight Stock Market, under the ticker SYNT)... |
| 10.03.2022 | SyntheticMR’s Board of Directors has resolved to carry out a directed new share issue of SEK 60 million, subject to subsequent approval by the Extraordinary General Meeting | SyntheticMR’s Board of Directors has resolved to carry out a directed new share issue of SEK 60 million, subject to subsequent approval by the Extraordinary General Meeting
Thu, Mar 10, 2022 23:00 CET Report this content
The Board of Direct... |
| 07.03.2022 | SyntheticMR proposes election of new board member | SyntheticMR proposes election of new board member
Mon, Mar 07, 2022 10:07 CET Report this content
The Nomination Committee of SyntheticMR has proposed to the Annual General Meeting 2022 that the Board will comprise five ordinary members wit... |
| 03.03.2022 | SyntheticMR Establishes Local Representation in China | SyntheticMR Establishes Local Representation in China
Thu, Mar 03, 2022 13:48 CET Report this content
SyntheticMR announces that they are establishing a sales and support representative based in Beijing, China. This will aid the company in ... |
| 22.02.2022 | Year-End report January – December 2021 | Year-End report January – December 2021
Tue, Feb 22, 2022 08:23 CET Report this content
Fourth quarter in brief
Net sales amounted to 18.4 million SEK (15.8), which means a sales growth of 16 percent.
Operating profit amounted to 5.2 millio... |
| 14.02.2022 | SyntheticMR : Nemours Children's Health to Implement SyntheticMR's product SyMRI in Clinical Practice | Nemours Children's Health will be integrating SyntheticMR's product SyMRI NEURO at their hospital in Orlando, Florida, to improve scan speed, provide myelin mapping and increase overall clinical efficiency.
Nemours Children's Health is a le... |
| 14.02.2022 | Nemours Children’s Health to Implement SyntheticMR’s product SyMRI in Clinical Practice | Nemours Children’s Health to Implement SyntheticMR’s product SyMRI in Clinical Practice
Mon, Feb 14, 2022 16:54 CET Report this content
Nemours Children’s Health will be integrating SyntheticMR’s product SyMRI NEURO at their hospital in Orl... |
| 08.02.2022 | SyntheticMR Partners with Hyland to Utilize PACSgear Modlink Software | SyntheticMR Partners with Hyland to Utilize PACSgear Modlink Software
Tue, Feb 08, 2022 09:50 CET Report this content
SyntheticMR US Inc finalized a new partnership with Hyland Healthcare utilizing their Enterprise Imaging Capture and Conne... |
| 27.01.2022 | SyMRI software is chosen for HEALthy Brain and Child Development (HBCD) study | SyntheticMR US Inc announces that SyMRI software has been chosen as an important technology to be used in the HEALthy Brain and Child Development (HBCD) Study that will follow a large cohort of pregnant women and their children to character... |
| 27.01.2022 | SyMRI software is chosen for HEALthy Brain and Child Development (HBCD) study | SyMRI software is chosen for HEALthy Brain and Child Development (HBCD) study Thu, Jan 27, 2022 13:13 CET
SyntheticMR US Inc announces that SyMRI software has been chosen as an important technology to be used in the HEALthy Brain and Child ... |
| 11.11.2021 | Interim report July – September 2021 | Interim report July – September 2021 Thu, Nov 11, 2021 08:05 CET
Third quarter in brief
Net sales amounted to 13.6 million SEK (10.5), which means a sales growth of 29 percent.
Operating profit amounted to 2.2 million SEK (-0.06).
Net profi... |
| 11.11.2021 | Interim report July - September 2021 | Third quarter in brief
Net sales amounted to 13.6 million SEK (10.5), which means a sales growth of 29 percent.
Operating profit amounted to 2.2 million SEK (-0.06).
Net profit for the period amounted to 2.3 million SEK (-0.15).
Earnings pe... |
| 10.11.2021 | SyntheticMR announces FDA clearance of new SyMRI release | SyntheticMR ABannounced today that its new SyMRI version was cleared by FDA for head imaging with significant improvements, including image quality and added functionality to the reference curves.
The work to get FDA clearance for the diffe... |
| 10.11.2021 | SyntheticMR announces FDA clearance of new SyMRI release | SyntheticMR announces FDA clearance of new SyMRI release Wed, Nov 10, 2021 18:06 CET
SyntheticMR AB announced today that its new SyMRI version was cleared by FDA for head imaging with significant improvements, including image quality and ad... |
| 08.11.2021 | Nomination Committee appointed for the 2022 Annual General Meeting in SyntheticMR | Nomination Committee appointed for the 2022 Annual General Meeting in SyntheticMR Mon, Nov 08, 2021 10:30 CET
The following shareholders have been identified as the three largest shareholders as of 2021-09-30 who are willing to be part of t... |
| 06.09.2021 | SyntheticMR signs global agreement with Philips to include SyntheticMR’s solution in third party product catalogue | SyntheticMR signs global agreement with Philips to include SyntheticMR’s solution in third party product catalogue Mon, Sep 06, 2021 08:30 CET
SyntheticMR has entered an agreement with Philips to include SyntheticMR’s medical imaging soluti... |
| 31.08.2021 | SyntheticMR : Presentation of SyMRI 3D at Canon's lunch symposium at JSMRM | SyntheticMR's software solution SyMRI will be featured in a presentation titled "Value of 3D Synthetic MRI in Clinical Imaging" at Canon Medical Systems' sponsored Lunch Symposium. Dr.
Shohei Fujita from the Department of Radiolog... |
| 31.08.2021 | Presentation of SyMRI 3D at Canon’s lunch symposium at JSMRM | Presentation of SyMRI 3D at Canon’s lunch symposium at JSMRM Tue, Aug 31, 2021 10:50 CET
SyntheticMR’s software solution SyMRI will be featured in a presentation titled “Value of 3D Synthetic MRI in Clinical Imaging” at Canon Medical System... |
| 31.08.2021 | SyntheticMR : Presentation of SyMRI 3D at Canon's lunch symposium at JSMRM | SyntheticMR's software solution SyMRI will be featured in a presentation titled 'Value of 3D Synthetic MRI in Clinical Imaging' at Canon Medical Systems' sponsored Lunch Symposium. Dr. Shohei Fujita from the Department of Radiology at Junte... |
| 27.08.2021 | Principal shareholders issue call options to senior executives in SyntheticMR | Principal shareholders issue call options to senior executives in SyntheticMR Fri, Aug 27, 2021 08:15 CET
SyntheticMR AB (publ) (”SyntheticMR”) announced today that leading executives (CEO and Head of US region) agreed on the purchase of a ... |
| 27.08.2021 | SyntheticMR : Principal shareholders issue call options to senior executives in SyntheticMR | SyntheticMR AB (publ) ("SyntheticMR") announced today that leading executives (CEO and Head of US region) agreed on the purchase of a total of 300 000 call options. The options are issued by SyntheticMR's principal shareholders (N... |
| 17.08.2021 | SyntheticMR and Siemens Healthineers collaboration extended - SyMRI NEURO now directly available through Siemens Healthineers | SyntheticMR and Siemens Healthineers collaboration extended - SyMRI NEURO now directly available through Siemens Healthineers Tue, Aug 17, 2021 15:16 CET
SyntheticMR have entered a general software license agreement for distribution with Si... |
| 13.07.2021 | Interim report April – June 2021 | Interim report April – June 2021 Tue, Jul 13, 2021 08:09 CET
Second quarter in brief
Net sales amounted to 11.8 million SEK (9.9), which means a sales growth of 19 percent.
Operating profit amounted to 0.1 million SEK (-3.0).
Net profit for... |
| 09.06.2021 | SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical Systems | SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical Systems Wed, Jun 09, 2021 14:30 CET
SyntheticMR announced today that they have entered a development project together with Juntendo University ... |
| 12.05.2021 | SYNTHETICMR AB (PUBL)
Correction of record date for share split: Record date for share split in SyntheticMR AB (publ) shall be 21 May 2021 | The Annual General Meeting (AGM) of SyntheticMR AB (publ) resolved on 11 May 2021 to split the company's shares, so called share split, whereby one (1) existing share is divided into ten (10) shares. After the share split, the number of sha... |
| 09.04.2021 | SYNTHETICMR AB (PUBL)
SyntheticMR : publishes annual report for 2020 | SyntheticMR AB (publ) hereby announces that the Group's annual report for 2020 has been published.
The annual report is also available on SyntheticMRs website www.syntheticmr.com
The english annual report is a translation of the swedish ver... |
| 24.03.2021 | SYNTHETICMR AB (PUBL)
SyntheticMR : receives first order from United Imaging | SyntheticMR AB announced today that they have received the first order from its new OEM partner, United Imaging. The order is for licenses of SyntheticMR's product package SyMRI NEURO, primarily intended for the Chinese market. SyntheticMR ... |
